About Labcorp Holdings Inc.
Labcorp Holdings Inc. (LH) has been publicly traded since 1990, making it a 36-year-old public company. It operates in the Diagnostics & Research industry within the Healthcare sector. The company is headquartered in Burlington, United States and employs approximately 61,770 people. With a market capitalization of $22 billion, LH is a large established company.
Key Statistics
- Current Price
- $263.80
- Market Cap
- $21.87B
- 52-Week High
- $293.72
- 52-Week Low
- $209.38
- Sector
- Healthcare
- Industry
- Diagnostics & Research
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +5.41% | $250.25 | $263.80 |
| 2025 | +10.62% | $226.24 | $250.25 |
| 2024 | +2.22% | $221.32 | $226.24 |
| 2023 | +13.82% | $194.44 | $221.32 |
| 2022 | -24.41% | $257.22 | $194.44 |
| 2021 | +54.37% | $166.63 | $257.22 |
| 2020 | +20.32% | $138.49 | $166.63 |
| 2019 | +33.88% | $103.44 | $138.49 |
| 2018 | -20.78% | $130.58 | $103.44 |
| 2017 | +24.25% | $105.10 | $130.58 |
| 2016 | +3.83% | $101.22 | $105.10 |
| 2015 | +14.59% | $88.33 | $101.22 |
| 2014 | +18.09% | $74.80 | $88.33 |
| 2013 | +5.48% | $70.91 | $74.80 |
| 2012 | +0.76% | $70.38 | $70.91 |
| 2011 | -2.22% | $71.97 | $70.38 |
| 2010 | +17.48% | $61.27 | $71.97 |
| 2009 | +16.19% | $52.73 | $61.27 |
| 2008 | -14.72% | $61.83 | $52.73 |
| 2007 | +2.80% | $60.15 | $61.83 |
| 2006 | +36.43% | $44.08 | $60.15 |
| 2005 | +8.09% | $40.78 | $44.08 |
| 2004 | +34.83% | $30.25 | $40.78 |
| 2003 | +58.99% | $19.03 | $30.25 |
| 2002 | -42.51% | $33.09 | $19.03 |
| 2001 | -8.12% | $36.02 | $33.09 |
| 2000 | +377.29% | $7.55 | $36.02 |
| 1999 | +168.18% | $2.81 | $7.55 |
| 1998 | -21.43% | $3.58 | $2.81 |
| 1997 | -39.13% | $5.88 | $3.58 |
| 1996 | -69.33% | $19.19 | $5.88 |
| 1995 | -29.25% | $27.12 | $19.19 |
| 1994 | -6.47% | $28.99 | $27.12 |
| 1993 | -18.65% | $35.64 | $28.99 |
| 1992 | -37.78% | $57.28 | $35.64 |
| 1991 | +168.62% | $21.32 | $57.28 |
Valuation
LH currently trades at a trailing P/E ratio of 25.2, which is considered high relative to the broader market. The forward P/E of 13.7 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 2.5. The price-to-sales ratio is 1.6.
Dividends
Labcorp Holdings Inc. pays a dividend to shareholders with a current yield of 1.09%. This translates to $2.88 per share annually. The payout ratio of 28% indicates sustainable dividend coverage.
Risk & Volatility
LH has a beta of 0.97, indicating it is similarly volatile to the overall market. The stock's 52-week range is $209.38 to $293.72, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 17 analyst opinions, LH has a consensus "buy" rating. The average price target of $307.71 suggests 16.6% upside from current levels.
Frequently Asked Questions
What does Labcorp Holdings Inc. do? ▼
Labcorp Holdings Inc. is a Diagnostics & Research company operating in the Healthcare sector. The company is headquartered in Burlington, United States.
What sector is LH in? ▼
LH operates in the Healthcare sector, specifically in the Diagnostics & Research industry.
When did LH go public? ▼
Labcorp Holdings Inc. went public in 1990, making it a 36-year-old public company as of 2026.
How much would $1,000 invested in LH 5 years ago be worth today? ▼
A $1,000 investment in LH five years ago would be worth approximately $1,347 today, representing a 34.7% return.
Does LH pay dividends? ▼
Yes, Labcorp Holdings Inc. pays a dividend with a current yield of 1.09%, which is $2.88 per share annually.
What is LH's market cap? ▼
Labcorp Holdings Inc. has a market capitalization of $22 billion, classifying it as a large-cap company.
What is LH's P/E ratio? ▼
LH has a trailing P/E ratio of 25.2 and a forward P/E of 13.7, which measures how much investors are paying per dollar of earnings.
Is LH a buy, hold, or sell? ▼
Based on 17 opinions, LH has a consensus "buy" rating. The average price target is $307.71.
Last updated: 3/14/2026